Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Type Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Large-scale testing (Phase 3)UnknownNCT01628081
What this trial is testing

The Effect of Alga Dunaliella Bardawil on Psoriasis

Who this might be right for
Psoriasis
Sheba Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00763555
What this trial is testing

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 88
Large-scale testing (Phase 3)Study completedNCT02207231
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 837
Early research (Phase 1)UnknownNCT03424629
What this trial is testing

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Tianjin Ever Union Biotechnology Co., Ltd. 57
Testing effectiveness (Phase 2)WithdrawnNCT02011269
What this trial is testing

TSO for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coronado Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT01029405
What this trial is testing

Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 145
Not applicableStudy completedNCT00708708
What this trial is testing

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Who this might be right for
Psoriasis
Pfizer 926
Testing effectiveness (Phase 2)Study completedNCT00885196
What this trial is testing

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Novartis Pharmaceuticals 336
Testing effectiveness (Phase 2)Study completedNCT05190419
What this trial is testing

Study to Assess the Efficacy and Safety of Orismilast in Psoriasis

Who this might be right for
PsoriasisSkin Diseases
UNION therapeutics 202
Large-scale testing (Phase 3)Study completedNCT01177800
What this trial is testing

Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Xian-Janssen Pharmaceutical Ltd. 129
Testing effectiveness (Phase 2)Study completedNCT04629950
What this trial is testing

Rimegepant in Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Weill Medical College of Cornell University 41
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Large-scale testing (Phase 3)Study completedNCT00688519
What this trial is testing

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Who this might be right for
Psoriasis
Stiefel, a GSK Company 336
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Large-scale testing (Phase 3)Study completedNCT01640951
What this trial is testing

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-Type Psoriasis
Novartis Pharmaceuticals 675
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Early research (Phase 1)Study completedNCT02940002
What this trial is testing

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Who this might be right for
Psoriasis
Bayer 23
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Testing effectiveness (Phase 2)Study completedNCT01107457
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation